First, the lack of important clinical-pathological features of clinical patients in our study, such as tumor invasion depth, distant metastasis, histological type, and TNM stage, influenced the results of the correlation between the expression of FAM22A-AS1 and the prognosis of CRC patients. The gene discussed is NUTM2A; the disease is neoplasm.